90Y-Epratuzumab Study Shows Improvement of Therapy Results Following R ... GlobeNewswire (press release) ... today reported that adding two doses of epratuzumab labeled with the radioisotope, yttrium-90 (90Y), to a combination of rituximab and CHOP chemotherapy (R-CHOP), the standard of care for patients with diffuse large B-cell lymphoma (DLBCL ... |
